PDF-Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov

Author : pasty-toler | Published Date : 2016-06-27

9 April EMA8165732011Rev 1 Draft agreed by ERMS FG24 January 2012 Draft adopted by Executive Director20 February 2012 Released for consultation21 February 2012 End

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Guideline on good pharmacovigilance prac..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov: Transcript

9 April EMA8165732011Rev 1 Draft agreed by ERMS FG24 January 2012 Draft adopted by Executive Director20 February 2012 Released for consultation21 February 2012 End of consultation deadline for co. New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. new look. MANAHOT ORIENTATION . September 13,2016. Personal Grooming Guideline for Female. Hai. r. . Clean and dandruff-free. . Well-trimmed and well-combed. . Hair length that is below neck level must be . New challenges for WHO. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Module 10:. Pharmacovigilance. Background – definitions. Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing use. Burden of adverse drug reactions in children. Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016). , MD. Pfizer, India. DISCLAIMER. Overview. Introduction & Terminology. Why Pharmacovigilance?. Pharmacovigilance Practices. : International & Indian. PVPI. Drug Safety Issues in Clinical Trials . Shanthi Pal. Leader, Medicines Safety. Safety . and Vigilance,. WHO, Geneva. What is pharmacovigilance. The science and activities relating to the detection, assessment, understanding and prevention of . & . Adverse Drug Reactions . Reporting systems. Dr. . Habab. Khalid . Elkheir. B.Pharm. ., . M.Pharm. ., PhD . ISOP. ISPE. IUATLD. SSCP. 11/28/2017. Habab khalid Elkheir. Objectives of the workshop. Monitoring the safety of medicines. Pharmacovigilance is the science and practices related to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. Dr Shanthi Pal. . Group Lead, Medicines Safety . . Director/EMP . K. De . Joncheere. Coordinator PAU. G. Forte. Head/RHT. L.Rago. Coordinator/PHI. M Zafar. Coordinator /PQT. Coordinator RSS. N Dellepiane. FEV VERSUS GROWTH AND MATURATION 317 MATERIALS AND METHODS Study population Subjects selected to illustrate this procedure were participants in the Tucson Epidemiological Study of Air- ways Obstructiv Elective and Emergency. Page 1 of 15 Caesarean Section: Elective & Emergency ( V. 10 ) Ratified Date: 19 th January 2016 Effective from : 22 nd January 2016 Review Date: 22 nd January 2019 Guidel Aimer : clinicians to help them provide quality medical care It should not be considered inclusive of all proper procedures and te sts or exclusive of other procedures and tests that are reasonably Author: Christine Burren Version: 0 1 Date: Jan 2016 Review Date: Jan 2019 Page 1 of 5 Guideline for the Management of Infant of Mother with Thyroid Disease Main Author(s): Christine Burren, Co No medicine is without . risk and the. . benefits of . a medicine must always be weighed up against its risks. . The . balance of benefits and risks should be effectively considered and must not be left to chance.

Download Document

Here is the link to download the presentation.
"Guideline on good pharmacovigilance practices (GVP)Module II Pharmacov"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.